CDE Catalog

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Displaying 1676 - 1700 of 1834
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification CRF Name Copyrighted or trademarked Disease Name Subdisease Name
C59992 Breathlessness submaximal absolute trial complete oxygen uptake peak Borg scale ratio value

Value, as a percentage, of the ratio of the scale value of breathlessness using the Borg Scale at the conclusion of the Submaximal Absolute Trial, to the scale value measured at the attainment of peak oxygen uptake (VO2)

Supplemental-Highly Recommended Staged Exercise Tolerance Test Mitochondrial Disease Mitochondrial Disease
C59989 Breathlessness submaximal absolute trial Borg scale

Scale value of breathlessness during the Submaximal Absolute Trial using the Borg Scale

Supplemental-Highly Recommended Staged Exercise Tolerance Test Mitochondrial Disease Mitochondrial Disease
C59988 Breathlessness rest Borg scale

Scale value of breathlessness at rest using the Borg Scale

Supplemental-Highly Recommended Staged Exercise Tolerance Test Mitochondrial Disease Mitochondrial Disease
C59991 Breathlessness oxygen uptake peak measure Borg scale

Scale value of breathlessness measured with the Borg Scale at the attainment of peak oxygen uptake (VO2)

Supplemental-Highly Recommended Staged Exercise Tolerance Test Mitochondrial Disease Mitochondrial Disease
C59740 Bone fracture mechanism type

The type of mechanism that caused the participant's fracture(s)

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C20006 Bone fracture indicator

The indicator related to having a bone fracture

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C59737 Bone fracture count

Count of fractures experienced by the participant

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C59742 Bone fracture confirmed medical record indicator

Indicator of whether the participant had their fracture confirmed in medical record

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C59739 Bone fracture anatomic site other text

Free-text field to specify other anatomic site of bone fractures

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C59738 Bone fracture anatomic site

The anatomic location of fractures experienced by the participant

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C59741 Bone fracture age value

Value for participant's age at the time of fracture

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C11131 Body mass index value

Value of the participant's body mass index, calculated from height and weight

Supplemental Physical Exam Mitochondrial Disease Mitochondrial Disease
C19634 Body mass index pediatric value

Value of the participant's body mass index, calculated from height and weight, age

Supplemental Physical Exam Mitochondrial Disease Mitochondrial Disease
C19571 Body mass index category

Categorization of the participant's body mass index

Supplemental Physical Exam Mitochondrial Disease Mitochondrial Disease
C19621 BMI Z score

The number of standard deviations the calculated BMI of the participant is above the mean

Supplemental Physical Exam Mitochondrial Disease Mitochondrial Disease
C19622 BMI standard infant use type

Indicator of whether WHO or CDC growth charts were used in BMI Z-score calculation

Supplemental Physical Exam Mitochondrial Disease Mitochondrial Disease
C19581 BMI Percentile Value

Value of the participant's BMI percentile for children over 2 years

Supplemental Physical Exam Mitochondrial Disease Mitochondrial Disease
C59745 BMI diabetes diagnosis category

Category of the participant's BMI (body mass index) at the time of diabetes diagnosis

Exploratory Diabetes-Related Medical History Mitochondrial Disease Mitochondrial Disease
C19516 Blood sample repository name

Name of repository to which the participant gave a blood sample

Supplemental Primary Mitochondrial Disease (PMD) Genetics Mitochondrial Disease Mitochondrial Disease
C59178 Blood sample repository indicator

Indicator whether the participant provided a blood sample to a repository

Supplemental Primary Mitochondrial Disease (PMD) Genetics Mitochondrial Disease Mitochondrial Disease
C60257 Blood sample identifier number

Identification (ID) number assigned to the blood sample in repository

Supplemental Primary Mitochondrial Disease (PMD) Genetics Mitochondrial Disease Mitochondrial Disease
C59974 Blood pressure systolic ventilatory anaerobic threshold measurement

Measurement, in millimeters of mercury (mmHg), of systolic blood pressure (BP) when the ventilatory anaerobic threshold (VAT) was attained

Supplemental-Highly Recommended Staged Exercise Tolerance Test Mitochondrial Disease Mitochondrial Disease
C60008 Blood pressure systolic trial start measurement

Measurement, in millimeters of mercury (mmHg), of the systolic blood pressure at the beginning of the exercise trial

Supplemental-Highly Recommended Staged Exercise Tolerance Test Mitochondrial Disease Mitochondrial Disease
C60049 Blood pressure systolic trial recovery start measurement

Measurement, in millimeters of mercury (mmHg), of the systolic blood pressure at the beginning of the trial recovery period

Supplemental-Highly Recommended Staged Exercise Tolerance Test Mitochondrial Disease Mitochondrial Disease
C60022 Blood pressure systolic trial other timepoint measurement

Measurement, in millimeters of mercury (mmHg), of the systolic blood pressure at the specified timepoint during the exercise trial

Supplemental-Highly Recommended Staged Exercise Tolerance Test Mitochondrial Disease Mitochondrial Disease
Displaying 1676 - 1700 of 1834

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.